Note: Ingredients listed on restricted chemical lists
EC/CAS
270-128-1/68411-46-1
Name of the chemical
benzenamine, N-phenyl-, reaction products with 2,4,4-trimethylpentene (BPTMP)
Concentration
<1.0
EC/CAS
209-909-9/597-82-0
Name of the chemical
O,O,O-triphenyl phosphorothioate
Concentration
0.1 - 0.5
General Information
Version
2.0
Revision date
2024-11-07
Product name
JAX Proofer Chain Oil
Emergency telephone
1-800-535-5053, 1-352-323-3500
Icons in SDS
Company Information
company name
JAX INC
e-mail address of the competent person responsible for the Safety Data Sheet
info@jax.com
GHS Information
Signal word
-
Hazard Codes
Hazard statements (CLP)
H411
Hazard statements
Code
Statements
H411
Toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
2.2 Label elements
Labelling
Hazard pictograms
GHS09
Hazard statements
H411 - Toxic to aquatic life with long lasting effects.
Precautionary statements
P391 - Collect spillage. Unknown acute toxicity (CLP) - SDS : 99.6% of the mixture consists of ingredient(s) of unknown acute toxicity (Oral) 99.6% of the mixture consists of ingredient(s) of unknown acute toxicity (Dermal) 99.45% of the mixture consists of ingredient(s) of unknown acute toxicity (Inhalation (Dust/Mist))
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH white mineral oil (petroleum) (8042-47-5), benzenamine, N-phenyl-, reaction products with regulation, in accordance with Annex XIII 2,4,4-trimethylpentene (68411-46-1) Substance(s) not meeting the vPvB criteria of REACH white mineral oil (petroleum) (8042-47-5), benzenamine, N-phenyl-, reaction products with regulation, in accordance with Annex XIII 2,4,4-trimethylpentene (68411-46-1) The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %